Slow Flow/No-Reflow After Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: A Meta-Analysis
Journal of Visualized Experiments · 2026-10-30 · (236)
DOI: 10.3791/74063 ↗At a glance
Video/Audio in Journal of Visualized Experiments, published online on 2026-10-30. Written by Jian Cheng and 2 co-authors. Institution: Department of Cardiovascular Medicine, Affiliated Jinhua Hospital, Zhejiang University School of Medicine (Jinhua Municipal Central Hospital); cj_330…. Major MEDLINE topics: Percutaneous Coronary Intervention, ST Elevation Myocardial Infarction, No-Reflow Phenomenon.
Abstract (original language)
Coronary slow flow/no-reflow after primary percutaneous coronary intervention (PCI) limits myocardial reperfusion in ST-segment elevation myocardial infarction (STEMI). Clinical, laboratory, angiographic, and procedural associations were synthesized while separating crude primary analyses from adjusted-only sensitivity analyses. Seven databases were searched from inception through May 31, 2026. Random-effects models used restricted maximum likelihood estimation and Hartung-Knapp confidence intervals; 95% prediction intervals were reported when at least three studies contributed. Forty-three observational studies included 27,405 patients, including 5,631 with slow flow/no-reflow. Crude pooled averages supported associations for diabetes mellitus, Killip class II or higher/acute heart failure, advanced Killip class, impaired baseline Thrombolysis in Myocardial Infarction flow, high thrombus burden, longer stent length, thrombus aspiration, and direct stenting, although several prediction intervals included the null. Adjusted-only analyses were consistent for age, hypertension, diabetes, Killip class II or higher/acute heart failure, and high thrombus burden. Outcome-definition and eligibility sensitivity analyses did not eliminate important uncertainty. Domain-based risk-of-bias judgments were predominantly some concerns or high concern, and Grading of Recommendations Assessment, Development and Evaluation certainty was low or very low. The review, therefore, provides a cross-domain evidence map rather than a causal catalog or bedside prediction score.
Subjects
MeSH terms (MEDLINE)
Authors and institutions
- Department of Cardiovascular Medicine, Affiliated Jinhua Hospital, Zhejiang University School of Medicine (Jinhua Municipal Central Hospital); cj_330@163.com.
- Department of Cardiovascular Medicine, Affiliated Jinhua Hospital, Zhejiang University School of Medicine (Jinhua Municipal Central Hospital).
Cite
APA
Cheng, J., Jin, Q., & Tang, B. (2026). Slow Flow/No-Reflow After Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: A Meta-Analysis. Journal of Visualized Experiments. https://doi.org/10.3791/74063
Vancouver
Cheng J, Jin Q, Tang B. Slow Flow/No-Reflow After Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: A Meta-Analysis. Journal of Visualized Experiments. 2026. doi:10.3791/74063
BibTeX
@article{Cheng2026,
author = {Cheng, Jian and Jin, Qiangsong and Tang, Biao},
title = {Slow Flow/No-Reflow After Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: A Meta-Analysis},
journal = {Journal of Visualized Experiments},
year = {2026},
number = {236},
doi = {10.3791/74063}
}
EUVIMED